Merck Hit With Antitrust Class Action Over Vaccine Data

Law360, New York (June 25, 2012, 5:05 PM EDT) -- Merck and Co. Inc. was hit with a putative antitrust class action in Pennsylvania federal court Friday by an Alabama medical provider alleging the pharmaceutical company lied about the efficacy rate of its mumps inoculation in an effort to keep competitors from bringing their own versions of the vaccine to market.

Chatom Primary Care PC accuses Merck of concealing test results and falsifying studies to artificially maintain the vaccine’s claimed 95 percent efficacy rate and intimidate rivals from producing their own version. Since 1967, Merck has...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

CHATOM PRIMARY CARE, P.C. v. MERCK & CO., INC.


Case Number

2:12-cv-03555

Court

Pennsylvania Eastern

Nature of Suit

Other Statutes: Anti-Trust

Judge

C. DARNELL JONES, II

Date Filed

June 25, 2012

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.